Monitor closely for compounding GI effects
Food and Drug Administration (2024) FDA drug shortages, U.S
Users can log injection dates, dosages, sites, and side effects, as well as track weight, protein, calories, and water intake
Some patients report ongoing symptoms such as persistent nausea, vomiting, abdominal pain, and delayed gastric emptying that do not resolve after discontinuation
Right now, the only oral GLP-1 medication available is Rybelsus, an oral form of semaglutide thats FDA-approved for type 2 diabetes but not yet for weight loss
This could mean the prescribed dosage or number of fills for Ozempic was listed incorrectly in the initial request for coverage